SCIENION has been 100% owned by CELLINK since August 2020.

At what enterprise value was SCIENION acquired in 2020?

During the acquisition of SCIENION by CELLINK in 2020, the transaction's Enterprise Value is estimated to be in the range of €50–150M.

What was the EV/EBITDA of SCIENION when it was acquired by CELLINK?

The estimated EV/EBITDA multiple for SCIENION is in the range of 15x - 25x.

What was the EV/Revenue multiple of SCIENION when it was acquired by CELLINK?

The estimated EV/Revenue multiple for SCIENION is in the range of 2x - 6x.

When was SCIENION acquired by CELLINK?

SCIENION was acquired by CELLINK in 2020.

What was the revenue of SCIENION at the time of the deal?

The revenue of SCIENION at the time of the deal is estimated to be in the range of €10–30M.

What was the EBITDA of SCIENION during the acquisition?

SCIENION's EBITDA is estimated to be in the range of €5–25M.

How is the data for the SCIENION acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the SCIENION deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cytena.com/company/press-releases-news/cellink-has-entered-into-an-agreement-to-acquire-precision-dispensing-company-scienion-ag/

What is the average EV/EBITDA multiple for the Industry & Manufacturing sector in 2026?

The average EV/EBITDA multiple for the Industry & Manufacturing sector in 2026 is 11.7x.

← DATABASE

Home Database Industry & ManufacturingSCIENION

08/2020

SCIENION acquired by CELLINK

GERMANY Industrial Equipment / Special Machinery / Lab & Scientific Equipment EV €50–150M

Context

Cellink has finalized a definitive agreement to acquire Scienion in a move designed to fundamentally transform its role in the global diagnostics and pharmaceutical markets. The strategic rationale for this transaction centers on a "vertical-integration" play, merging the target's industry-leading technical operational depth in precision picoliter dispensing with the group’s established global leadership in bioprinting and single-cell handling. This structural alignment provides the organization with the scientific talent and high-performance hardware—specifically the target's proprietary dispensing platforms—required to address the increasing demand for standardized high-throughput production of clinically approved diagnostic devices.

SCIENION, which reported an EBITDA margin of [members only] in 2019, is valued in this transaction at an EV/EBITDA multiple of 15x–25x, representing a premium to the average currently observed in the Industry & Manufacturing sector (11.7x).

-> Deep-dive in Industry & Manufacturing market trends

Target

Scienion AG is a Germany company specialized in Life Sciences Tools. The company has carved out a distinct space in the biotechnology market by focusing on the "inkjet-like" precision handling of even the most sensitive biological molecules. Instead of standard liquid handling, they thrive on a philosophy of ultra-low volume dispensing, allowing researchers to spot DNA, proteins, and human cells in the picoliter and nanoliter range with absolute accuracy. What makes them a go-to partner for the diagnostic and pharmaceutical sectors is their ability to scale from early-stage laboratory discovery to the high-throughput manufacturing of millions of diagnostic devices.

Ent. Value

€50–150M

Equity Value

[members only]

Multiples

EV / Revenue

2x–6x

EV / EBITDA

15x–25x

EV / EBIT

[members only]

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2019

2018

Similar deals in Industrial Equipment

List of similar M&A transactions (Date, Acquirer, Target, Country, Sub-sector)
Date	Acquirer	Target	Country	Sector
10/2020	THE CARLYLE GROUP	FLENDER	GERMANY	Special Machinery
10/2020	MAREL	TREIF MASCHINENBAU	GERMANY	Food & Beverage Lines
08/2020	HLD	MICROWAVE VISION (MVG)	FRANCE	Instrumentation & Measurement
06/2020	THE CARLYLE GROUP	ENVEA	FRANCE	Instrumentation & Measurement
02/2020	HALMA	SENSIT TECHNOLOGIES	UNITED STATES	Instrumentation & Measurement
02/2020	ADVENT INTERNATIONAL / CINVEN	TKE (THYSSENKRUPP ELEVATOR)	GERMANY	Special Machinery
01/2020	IDEX CORPORATION	FLOW MANAGEMENT DEVICES	UNITED STATES	Instrumentation & Measurement
12/2019	IK PARTNERS	MDT technologies	GERMANY	Electrical Equipment
12/2019	NORDIC CAPITAL	CONSILIUM SAFETY GROUP	SWEDEN	Safety & Security
12/2019	MAREL	CURIO	ICELAND	Food & Beverage Lines

REFERENCES

Valuation range: EV €50–150M

Revenue range: €10–30M

EBITDA range: €5–25M

EV/Revenue range: 2x - 6x

EV/EBITDA range: 15x - 25x

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of SCIENION by CELLINK are reserved for mynth community members. Register for free to unlock full data.

Authors: This transaction was contributed by a verified mynth contributor and cross-checked against available transaction documents and official company communications.

Acquirer: cellink